104 related articles for article (PubMed ID: 16980974)
1. Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies.
Lee H; Zahra D; Vogelzang A; Newton R; Thatcher J; Quan A; So T; Zwirner J; Koentgen F; Padkjaer SB; Mackay F; Whitfeld PL; Mackay CR
Nat Biotechnol; 2006 Oct; 24(10):1279-84. PubMed ID: 16980974
[TBL] [Abstract][Full Text] [Related]
2. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
[TBL] [Abstract][Full Text] [Related]
3. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
Lee H; Whitfeld PL; Mackay CR
Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
[TBL] [Abstract][Full Text] [Related]
4. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
[TBL] [Abstract][Full Text] [Related]
5. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
[TBL] [Abstract][Full Text] [Related]
6. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
[TBL] [Abstract][Full Text] [Related]
7. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
8. The roles of a ribosomal protein S19 polymer in a mouse model of carrageenan-induced acute pleurisy.
Yamanegi K; Kawakami T; Yamada N; Kumanishi S; Futani H; Nakasho K; Nishiura H
Immunobiology; 2017 May; 222(5):738-750. PubMed ID: 28190533
[TBL] [Abstract][Full Text] [Related]
9. C5aR-mediated myocardial ischemia/reperfusion injury.
Zhang H; Qin G; Liang G; Li J; Barrington RA; Liu DX
Biochem Biophys Res Commun; 2007 Jun; 357(2):446-52. PubMed ID: 17416341
[TBL] [Abstract][Full Text] [Related]
10. Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation.
Skokowa J; Ali SR; Felda O; Kumar V; Konrad S; Shushakova N; Schmidt RE; Piekorz RP; Nürnberg B; Spicher K; Birnbaumer L; Zwirner J; Claassens JW; Verbeek JS; van Rooijen N; Köhl J; Gessner JE
J Immunol; 2005 Mar; 174(5):3041-50. PubMed ID: 15728518
[TBL] [Abstract][Full Text] [Related]
11. Analysis of C5a receptor by monoclonal antibody.
Watanabe H; Kuraya M; Kasukawa R; Yanagisawa H; Yanagisawa M; Fujita T
J Immunol Methods; 1995 Sep; 185(1):19-29. PubMed ID: 7665898
[TBL] [Abstract][Full Text] [Related]
12. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis.
Mullaly SC; Kubes P
Eur J Immunol; 2007 Jan; 37(1):224-34. PubMed ID: 17154261
[TBL] [Abstract][Full Text] [Related]
13. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in tubular epithelial cells of human, murine and rat kidneys.
Kiafard Z; Tschernig T; Schweyer S; Bley A; Neumann D; Zwirner J
Immunobiology; 2007; 212(2):129-39. PubMed ID: 17336833
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice.
Tsuboi N; Ernandez T; Li X; Nishi H; Cullere X; Mekala D; Hazen M; Köhl J; Lee DM; Mayadas TN
Arthritis Rheum; 2011 Feb; 63(2):467-78. PubMed ID: 21280001
[TBL] [Abstract][Full Text] [Related]
15. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor.
Höpken UE; Lu B; Gerard NP; Gerard C
J Exp Med; 1997 Aug; 186(5):749-56. PubMed ID: 9271590
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
[TBL] [Abstract][Full Text] [Related]
17. Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus.
Saitoh R; Ohtomo T; Yamada Y; Kamada N; Nezu J; Kimura N; Funahashi S; Furugaki K; Yoshino T; Kawase Y; Kato A; Ueda O; Jishage K; Suzuki M; Fukuda R; Arai M; Iwanari H; Takahashi K; Sakihama T; Ohizumi I; Kodama T; Tsuchiya M; Hamakubo T
J Immunol Methods; 2007 Apr; 322(1-2):104-17. PubMed ID: 17374538
[TBL] [Abstract][Full Text] [Related]
18. Signaling through C5aR is not involved in basal neurogenesis.
Bogestål YR; Barnum SR; Smith PL; Mattisson V; Pekny M; Pekna M
J Neurosci Res; 2007 Oct; 85(13):2892-7. PubMed ID: 17551982
[TBL] [Abstract][Full Text] [Related]
19. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.
Zwirner J; Götze O; Begemann G; Kapp A; Kirchhoff K; Werfel T
Immunology; 1999 May; 97(1):166-72. PubMed ID: 10447728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
